| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1823 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 483 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 445 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 291 | 2024 |
| The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis B Sartorius, AP Gray, ND Weaver, GR Aguilar, LR Swetschinski, KS Ikuta, ... The Lancet Global Health 12 (2), e201-e216, 2024 | 106 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099, 2024 | 89 | 2024 |
| Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases 24 (9), 974-1002, 2024 | 51 | 2024 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 48 | 2023 |
| Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria OA Adejumo, B Olusola-Faleye, V Adepoju, A Bowale, S Adesola, ... African health sciences 18 (3), 472-478, 2018 | 47 | 2018 |
| Childhood tuberculosis in Nigeria: disease presentation and treatment outcomes CL Ogbudebe, V Adepoju, C Ekerete-Udofia, E Abu, G Egesemba, ... Health services insights 11, 1178632918757490, 2018 | 40 | 2018 |
| Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 JR Ledesma, J Ma, M Zhang, AVL Basting, HT Chu, A Vongpradith, ... The Lancet infectious diseases 24 (7), 698-725, 2024 | 33 | 2024 |
| Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000–2021: results from the Global Burden of Disease Study 2021 ME Moberg, EB Hamilton, SM Zeng, D Bryazka, JT Zhao, R Feldman, ... The Lancet Public Health 8 (11), e839-e849, 2023 | 26 | 2023 |
| Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria O Oladimeji, V Adepoju, FE Anyiam, JE San, BA Odugbemi, FLM Hyera, ... PLoS One 16 (1), e0244581, 2021 | 25 | 2021 |
| Trend of tuberculosis case notification and treatment outcome in Lagos State, Nigeria: a 5-year retrospective study OA Adejumo, OJ Daniel, HA Abdur-Razzaq, YO Shogbamimu, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 111 (7 …, 2017 | 19 | 2017 |
| The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria OA Adejumo, B Olusola-Faleye, VA Adepoju, M Gidado, MO Onoh, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 114 (6 …, 2020 | 17 | 2020 |
| Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors JOI Victor Adepoju, Chidubem Ogbudebe, Olusola Adedeji Adejumo, Okolie Johnson Journal of Global Infectious Diseases 12 (2), 105, 2020 | 16 | 2020 |
| Challenges of tuberculosis control in Lagos State, Nigeria: A qualitative study of health‑care providers’ perspectives OA Adejumo, OJ Daniel, VA Adepoju, T Femi-Adebayo, BI Adebayo, ... Nigerian Medical Journal 61 (1), 37-41, 2020 | 14 | 2020 |
| Do private health providers adhere to National Tuberculosis Guideline while assigning treatment outcome? Findings from a lower middle-income country VA Adepoju, OA Adejumo, OE Adepoju, MO Adeniyi, V Etuk, I Nzekwe, ... Frontiers in Public Health 10, 924132, 2022 | 11 | 2022 |
| Treatment-shortening regimens for tuberculosis: updates and future priorities F Saluzzo, VA Adepoju, R Duarte, C Lange, PPJ Phillips Breathe 19 (3), 2023 | 10 | 2023 |
| Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 Y Jin, C Guo, M Abbasian, M Abbasifard, JH Abbott, A Abdullahi, A Abedi, ... Med 5 (8), 943-962. e6, 2024 | 8 | 2024 |
